WAT Stock Recent News

Waters' (WAT) second-quarter results are hurt by weak end-market momentum and softness in Asia, Americas and Europe.

Waters Corporation (NYSE:WAT ) Q2 2024 Earnings Conference Call July 31, 2024 8:00 AM ET Company Participants Caspar Tudor - Head of Investor Relations Udit Batra - President and Chief Executive Officer Amol Chaubal - Senior Vice President and Chief Financial Officer Conference Call Participants Vijay Kumar - Evercore ISI Dan Brennan - TD Cowen Tycho Peterson - Jefferies Rachel Vatnsdal - JPMorgan Dan Arias - Stifel Jack Meehan - Nephron Research Catherine Schulte - Baird Operator Good morning. Welcome to the Waters Corporation Second Quarter 2024 Financial Results Conference Call.

Although the revenue and EPS for Waters (WAT) give a sense of how its business performed in the quarter ended June 2024, it might be worth considering how some key metrics compare with Wall Street estimates and the year-ago numbers.

Waters (WAT) came out with quarterly earnings of $2.63 per share, beating the Zacks Consensus Estimate of $2.55 per share. This compares to earnings of $2.80 per share a year ago.

Highlights Sales of $709 million exceeded guidance on a reported basis, declined 4% as reported and 4% in organic constant currency GAAP EPS of $2.40; earnings exceeded guidance with non-GAAP EPS of $2.63, led by strong operational performance Beat driven by better-than-expected performance in China, as well as higher-than-expected M&A contribution to overall sales from Wyatt Ex-China organic constant currency sales growth as expected across Pharma, Industrial, and Academic & Government end markets Full-year outlook reflects the potential for a more gradual market improvement in the second half of the year than previously anticipated Second Quarter 2024 MILFORD, Mass. , July 31, 2024 /PRNewswire/ -- Waters Corporation (NYSE: WAT) today announced its financial results for the second quarter of 2024.

Waters' (WAT) second-quarter 2024 results are likely to reflect strength in the large molecule and PFAS testing markets amid weakening demand in China.

Waters (WAT) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.

News Summary: Reduces sample volume requirements by 25x through use of advanced microfluidic technologies while increasing throughput up to 24x compared with competitor capillary DSC technologiesi. Streamlines thermal stability testing of biologics using disposable microfluidic chips (MFCs) enabling analysis under actual high-concentration drug dosing and use conditions.

MILFORD, Mass. , July 2, 2024 /PRNewswire/ -- Waters Corporation (NYSE:WAT) will hold its Q2 2024 financial results conference call live on Wednesday, July 31st, 2024 at 8:00 a.m.

Eurofins Scientific shares plunged on Monday after Muddy Waters Research said in a report it had started shorting the laboratory-services company, alleging founder and Chief Executive Gilles Martin has spent decades “covertly enriching” himself through improper real-estate deals.